Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome have?
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome has 92 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome published?
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome has 2014 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome?
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome has bronze oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome?
The DOI for Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome is on the source record.
What is the PMID of Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome?
The PMID for Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome is on the source record.
What is the OpenAlex record for Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome?
The OpenAlex for Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome is on the source record.